Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

DOI10.17615/p0k8-y378zbMATH Open1429.62551OpenAlexW4298677188WikidataQ30655744 ScholiaQ30655744MaRDI QIDQ2861966FDOQ2861966

Authors: Brent A. Johnson, Heather Ribaudo, Roy M. Gulick, Joseph J. jun. Eron 

Publication date: 13 November 2013

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.17615/p0k8-y378

Recommendations

• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095
• Segmental modeling of changing immunologic response for CD4 data with skewness, missingness and dropout
• Viral suppression in HIV studies: combining times to suppression and rebound
• Missing Time-Dependent Covariates in Human Immunodeficiency Virus Dynamic Models
• Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients

zbMATH Keywords

causal inferencepropensity scoreobservational datainformative censoring

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Cites Work

• Title not available (Why is that?)
• Marginal Mean Models for Dynamic Regimes
• Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials
• Estimating Mean Response as a Function of Treatment Duration in an Observational Study, Where Duration May Be Informatively Censored
• Semiparametric inference in observational duration-response studies, with duration possibly right-censored
• Treatment-competing events in dynamic regimes
• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095

Cited In (2)

• Estimating mean potential outcome under adaptive treatment length strategies in continuous time
• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095

This page was built for publication: Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2861966)